Los Angeles, California (PressExposure) February 14, 2013 -- The OMICS Group would organize the 4th Conference on Biomarkers and Clinical Research from July 15-17, 2013. The theme of the conference is "Impact of Biomarkers Development in Health Diagnostics and Clinical Research".
The meet would shed light on functional and profiling techniques, molecular approaches to biomarkers, microbial infections, biomarkers for disorders, biomarkers and the role of nanoparticles.
The 4th biomarkers and clinical conference would also focus on biomarkers of inducing and response, data statistics and other analytical methods for biomarkers. The other tracks to be covered are functional transcriptomics and profiling techniques, and Current research in Biomarkers development.
OMICS Inc. organizes scientific conferences at various venues throughout the calendar year, in order to promote advancement of scientific and medical research under specialized disciplines.
Biomarkers studies are a relatively new discipline which is a part of the mainstream biological sciences. A biomarker is basically a signature molecule that helps to identify certain type of biological tendencies or conditions at the cellular level. The clinical research associated with these studies goes a long way in the progress of detecting any kinds of disorders at an early stage. The meet is also a part of clinical research conferences that occur internationally throughout the calendar year.
The biomarkers are also helpful in identifying various disease pathways by studying the underlying gene expression profiles. MMPs are looked for cancer while serum LDL for cholesterol and hypertension. The advent of new techniques also raises a question as to the methodology followed in drug development. The various options available for biomarkers' development are immune cell profiling, gene expression profiling and scans depicting genomes.
Biomarkers also contribute to the practice of personalized medicine. Physicians hope they could soon customize treatment for rheumatoid arthritis patients. Biomarkers are also used to study the effect of dosages, and the biomarker serves as a surrogate endpoint in case the treatment affects its shape. The KRAS gene and protein is a special type of biomarker, whose sequence is used to study colorectal cancer.
The OMICS Conference of Biomarkers and Clinical Research would gather experts from the concerned discipline and bring together industry professionals, in addition to boosting the prospects of networking opportunities among various delegates. Researchers with a track record of over 200 papers are invited by OMICS Group to speak about the latest avenues in biomarkers development. The biomarkers research also leads to re-evaluation of drugs and clinical research associated with the same. This also suggests a change in clinical research and health diagnostics.